Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05964127Not ApplicableUnknown

Peri-implantitis and Systemic Inflammation

Role: lead

NCT05648305Completed

The Influences of Root Canal Complexity and Clinician Training on Root Canal Treatment Outcomes.

Role: collaborator

NCT04000854Not ApplicableUnknown

Regenerative Treatment of Traumatized Immature Permanent Incisors With Pulp Necrosis

Role: collaborator

NCT04668911Unknown

Oral Health, Microbial Burden and COVID-19

Role: lead

NCT02460926Not ApplicableCompleted

Acute Phase Response & Periodontal Treatment

Role: collaborator

NCT00327561Phase 3Completed

Effect of Intensive Periodontal Therapy on Vascular Function

Role: lead

All 6 trials loaded